Sitemap
About HBM Partners
Portrait
Investment Manager
Investment Advisor Europe
Investment Advisor USA
Newsletter
Investment Products
HBM BioVentures
HBM BioCapital
Portfolio
BioPharma
Current Portfolio
Past Portfolio
Devices / Diagnostics
Current Portfolio
Past Portfolio
News
News 2011
July - December
January - June
News 2010
July - December
January - June
News 2009
July - December
January - June
News 2008
July - December
January - June
Newsletter
Contact
Investment Advisor Europe
Investment Advisor USA
Investment Manager
Contact Form
News
PTC licenses Spinal Muscular Atrophy programme to Roche
(12 KB)
Ellipse receives award for best new technology in spine care
(29 KB)
Probiodrug announces top-line results of the first clinical study of PQ912 for treatment of Alzheimer's disease
(44 KB)
Archive
M&A Report
HBM Pharma/Biotech M&A Report
Links
HBM BioVentures
Subscribe To Our Newsletter
Subscribe here
Search
Search term
TOP
|
SITEMAP
|
CREDITS
|
IMPORTANT LEGAL INFORMATION
http://www.hbmpartners.com/en/sitemap/index.php
© HBM Partners AG 23.02.2012
PTC licenses Spinal Muscular Atrophy programme to Roche
